BOLT vs VMC · rev $7.7M vs P/E 35, rev $7.42B
Bolt Biotherapeutics (BOLT) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
BOLT currently screens at market cap $11.3M. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the BOLT and VMC stock pages for the full models.
Not investment advice.